Project description
1. Introduce advanced concepts, excellent foundations, and clinical research results from international blood oncology clinical research, and transform them into clinical practice. 2. Create conditions to join the international team of blood oncology clinical research, participate in international multicenter clinical trials, bring data from China to international blood oncology clinical research, and voice China's voice. 3. Introduce foreign intelligence and strengthen international cooperation, To improve one's own clinical research level and gradually align with international high-level clinical research. The basic and clinical research of hematological tumors represented by lymphoma and multiple myeloma has undergone rapid progress in recent years, with significant advancements in pathological diagnosis, the emergence of new drugs, and the presentation of new clinical research results. This has greatly changed the pattern of hematological tumor diagnosis and treatment. These advanced concepts, excellent basic and clinical research achievements urgently need to be introduced into China and transformed into clinical practice. At the same time, the research and development of new drugs and hematological clinical oncology are increasingly showing a global trend. International multicenter clinical research has greatly changed the current clinical practice of oncology, joining the international team of hematological oncology clinical research, participating in international multicenter clinical trials, and bringing data from China to the forefront of international hematological clinical oncology research, It is also the responsibility of Chinese clinical hematology workers to be others. Therefore, it is an urgent task for us to introduce foreign intelligence, strengthen international cooperation, and improve our clinical research level, gradually aligning with international high-level clinical research.